Susan Resnick, OD
Optometrist · New York, NYNPI 1356470900
Payments from drug & device makers
Across 846 payments — averaging $547.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$252K
- Sight Sciences, Inc.$80K
- Bausch & Lomb Americas Inc.$65K
- Johnson & Johnson Vision Care, Inc.$26K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$14K
- Visioneering Technologies, Inc.$11K
- plus $17K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 396 | $251,752 |
| Sight Sciences, Inc. | 107 | $79,838 |
| Bausch & Lomb Americas Inc. | 108 | $64,624 |
| Johnson & Johnson Vision Care, Inc. | 68 | $26,000 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 37 | $13,814 |
| Visioneering Technologies, Inc. | 11 | $10,687 |
| Alcon Research LLC | 6 | $4,782 |
| AbbVie(2 entities) | 12 | $2,974 |
| Johnson & Johnson Surgical Vision, Inc. | 9 | $2,687 |
| Glaukos Corporation | 3 | $1,980 |
| Tarsus Pharmaceuticals, Inc. | 13 | $1,524 |
| Coopervision Inc. | 16 | $939 |
| Sun Pharmaceutical Industries Inc. | 22 | $385 |
| Oyster Point Pharma, Inc. | 14 | $302 |
| LKC Technologies, Inc. | 2 | $273 |
| Topcon Healthcare, Inc. | 1 | $215 |
| Novartis | 10 | $214 |
| Dompe US, Inc. | 4 | $94 |
| Biotissue Holdings Inc. | 1 | $88 |
| Harrow Eye, LLC | 2 | $40 |
| Osmotica Pharmaceutical Corp. | 1 | $23 |
| Kala Pharmaceuticals, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
How this compares
$463,292 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in New York
- George ZikosNew York$1M
- Irene FrantzisNew York$663K
- Daphne AmbroseNew York$509K
- Denise WhittamNew York$343K
- Jennifer TsaiNew York$275K
- Sophia VisanjiNew York$233K
- Danielle IaconoNew York$206K
- Jason ComptonNew York$197K
- John RobilottoNew York$155K
- Arkady SelenowNew York$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.